⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Peoria Community Unites at 2026 Susan G. Komen ® MORE THAN PINK Walk
businesswire.com
BAC
NTRA
GH
NVS
LLY
CAT
The Psoriasis Clinical Trial Pipeline Boom as 90+ Companies are in the Race for Better Treatments | DelveInsight
globenewswire.com
JNJ
PFE
ABBV
LLY
AMGN
INCY
GILD
BHC
AZN
SUN
Orlando Community Unites at 2026 Susan G. Komen ® MORE THAN PINK Walk
businesswire.com
BAC
NTRA
GH
NVS
LLY
Linden Lake Labs Applauds Acquisition of Portfolio Company CrossBridge Bio by Eli Lilly and Company
businesswire.com
LLY
CrossBridge Bio Enters an Agreement to be Acquired by Eli Lilly to Advance Next-Generation Dual-Payload Antibody-Drug Conjugates
businesswire.com
LLY
CRBG
Vasa Therapeutics Partners with Lilly TuneLab to Power AI/ML-Driven CAMKII Inhibitor Platform
prnewswire.com
LLY
Francois Schramek Promoted to Partner at Manhattan West
prnewswire.com
AI
AMN
GM
LMT
NVDA
GOOG
MSFT
SPCE
RKLB
GD
BA
AMD
INTC
META
CRWD
PLTR
AN
DD
HON
RTX
IBM
AMZN
TSLA
XOM
CVX
UNH
BMY
PFE
MRK
JNJ
LLY
GILD
REGN
BIIB
AMGN
AZN
NVO
SNY
TEVA
BABA
JD
NTES
BIDU
IQ
VIPS
BZUN
HTHT
MELI
BBD
BB
ERIC
NOK
QCOM
MU
ADSK
CRM
GOOGL
Lyumjev (Eli Lilly and Co) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
LLY
Lilly's Jaypirca (pirtobrutinib) significantly extended progression-free survival when added to a venetoclax time-limited regimen in patients with previously treated CLL/SLL
prnewswire.com
LLY
Dementia Market Insight, Epidemiology, and Forecasts, 2022-2025 & 2026-2034
globenewswire.com
BIIB
LLY